The assay is designed to detect ribosomal RNA from four clinically relevant Babesia species and runs on the company's Procleix Panther system.
The New York Times warns in an editorial that 23andMe health risk tests may not provide useful information.
Direct-to-consumer genetic testing firm 23andMe has a newly cleared colorectal cancer risk test.
The clearance enables 23andMe to report on the two most common variations in the MUTYH gene influencing MAP, which increases risk of CRC development.
According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
Data from the GUIDED study will be central to commercial payor discussions, a Medicare LCD reconsideration request, and eventually expansion into the primary care market.
Sequencing has helped identify where an E. coli outbreak may have originated, the Atlanta Journal-Constitution reports.
The partial federal government shutdown in the US affects a number of science agencies, ScienceInsider reports.
The test is the second of three panels intended to detect pathogens that cause the bloodstream infections that can lead to sepsis.
According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.
An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.
US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.
In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.